Dow Down0.17% Nasdaq Down0.28%

AcelRx Pharmaceuticals, Inc. (ACRX)

-NGM
5.49 Down 0.41(6.95%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 71   95   27,607   548  
Cost of Revenue -   -   -   -  
Gross Profit 71   95   27,607   548  
Operating Expenses
Research Development7,284  4,711  4,318  6,548  
Selling General and Administrative5,047  3,925  3,306  2,310  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (12,260) (8,541) 19,983   (8,310)
Income from Continuing Operations
Total Other Income/Expenses Net2,215  (618)(1,901)(2,328)
Earnings Before Interest And Taxes(10,045)(9,159)18,082  (10,638)
Interest Expense530  472  313  348  
Income Before Tax(10,575)(9,631)17,769  (10,986)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(10,575)(9,631)17,769  (10,986)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (10,575) (9,631) 17,769   (10,986)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (10,575) (9,631) 17,769   (10,986)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.